Denali Therapeutics
DNLI
#3996
Rank
โ‚ฌ2.48 B
Marketcap
16,93ย โ‚ฌ
Share price
0.00%
Change (1 day)
-28.32%
Change (1 year)

Denali Therapeutics (DNLI) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ0.90 Billion

According to Denali Therapeutics 's latest financial reports the company's total assets are โ‚ฌ0.90 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Denali Therapeutics - Total assets on balance sheet (from 2016 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ1.32 B26.51%
2023-12-31โ‚ฌ1.04 B-23.32%
2022-12-31โ‚ฌ1.36 B9.79%
2021-12-31โ‚ฌ1.23 B-4.94%
2020-12-31โ‚ฌ1.30 B164.11%
2019-12-31โ‚ฌ0.49 B-14.66%
2018-12-31โ‚ฌ0.57 B42.65%
2017-12-31โ‚ฌ0.40 B57.41%
2016-12-31โ‚ฌ0.25 B668.13%
2015-12-31โ‚ฌ33.54 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novocure
NVCR
โ‚ฌ1.17 B 28.95% Jersey
Novavax
NVAX
โ‚ฌ1.01 B 11.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
โ‚ฌ12.59 M-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚ฌ0.17 B-80.84%๐Ÿ‡ฌ๐Ÿ‡ง UK